ARTICLE | Clinical News

Xifaxan rifaximin regulatory update

October 11, 2010 7:00 AM UTC

FDA extended the PDUFA date for an sNDA from Salix for Xifaxan rifaximin 550 mg tablets by 3 months to March 7, 2011, from Dec. 7. According to Salix, the agency requires additional time to review the...